48 citations
,
July 2009 in “The Journal of Sexual Medicine” DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.
46 citations
,
May 2009 in “Maturitas” Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.
31 citations
,
December 2016 in “Anais Brasileiros de Dermatologia” The document reviewed the role of transforming growth factor-beta 1 (TGFβ1) in promoting fibrosis and its interaction with peroxisome proliferator-activated receptor (PPAR), which negatively regulates fibrotic events. Dehydroepiandrosterone (DHEA), an immunomodulatory hormone crucial for PPAR functions, was noted to be reduced in fibrotic processes. The study highlighted that while scarring alopecia often occurs during a period of decreased DHEA production in females, there was no existing literature directly linking DHEA reduction to the fibrogenic process in frontal fibrosing alopecia. The article aimed to explore the fibrogenic activity of TGFβ1, its regulation by PPAR, and its connection with DHEA in the context of frontal fibrosing alopecia.
9 citations
,
November 2008 in “Journal of Womens Health” Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.
9 citations
,
February 2020 in “International Journal of Endocrinology” Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.